Article
05 Aug 2021
Ushering In A New Era: FDA Approves First Interchangeable Biosimilar
AUTHORS CONTENT
Article
14 Jun 2021
HHS Issues Buprenorphine Practice Guidelines As Study Confirms Access Barriers
Article
07 May 2021
FDA Ups The Ante And Sends First Notice Of Noncompliance For Failure To Submit Clinical Trial Results
Article
29 Mar 2021
CBD Regulatory Enforcement Continues With Over-the-Counter CBD Pain Relief Products
Article
10 Feb 2021
Working Together, FDA, NTIA, And Domain Registries Take Down 30 Websites Illegally Selling Opioids
Article
29 Jan 2021
Recent Amendments To The FDA Laws Attempt To Clarify And Improve Existing Systems
Article
26 Nov 2020
Are Speaker Programs A Thing Of The Past? OIG's Fraud Alert Indicates It Thinks They Should Be
Article
14 Nov 2020
DEA Releases Long-Awaited Suspicious Orders Proposed Rule
Article
04 Sep 2020
Introduction To The Due Diligence Process, Second Edition (Video)
Article
25 Aug 2020
OTC Monograph Reform: Key Takeaways And What Industry Can Expect
Article
19 Aug 2020
Federal Appeals Court Affirms Lower Court Ruling: Drug Pricing Transparency Rule Exceeds HHS's Regulatory Authority
Article
11 Aug 2020
FDA Greenlights Updates To The Purple Book Database
Article
30 May 2020
FDA Reverses Decision To Authorize Use Of Chinese KN95 Respirators
Article
04 May 2020
CARES Act Creates And Updates Drug And Medical Device Shortage Requirements
Article
17 Dec 2019
Drugs, Biologics, And Regenerative Medicine In 2019: A Successful Year Ends With Promise Of A More Challenging 2020
Article
04 Dec 2019
Key Vote In FDA Commissioner Confirmation Process Set For December 3rd
Article
18 Nov 2019
FDA Issues Drug Shortage Report Identifying Root Causes And Potential Solutions
Article
08 Oct 2019
HHS Files Brief In D.C. Circuit Supporting Drug Pricing Transparency Rule
Article
28 Aug 2019
HHS Drug Pricing Disclosure Rule: Chance At A Renewed Life Following District Court Appeal?
Article
16 Aug 2019
Congress Looking To Streamline CBD Drug Research